The b 1 -adrenergic receptor (b 1 -AR) belongs to the largest super family of G-protein-coupled receptors (GPCRs). The b 1 -AR responds to norepinephrine and epinephrine by activating adenylyl cyclase pathway and promotes production of cAMP.1) Activation of cardiac b-adrenergic receptors plays an important role in regulating the physiological responses of the heart to an increase demand.2) The pathophysiology of human b 1 -ARs is associated with several cardiovascular diseases such as dilated cardiomyopathy, congestive heart failure, ventricular arrhythmia and sudden death. [3][4][5] Recently, several GPCRs have exhibited constitutive activity and inactivity in vivo. Naturally occurring amino acid mutations in the luteinizing hormone receptor, 6) parathyroid hormone receptor, 7) melanocyte-stimulating hormone receptor, 8) thyrotropin receptor 9) and rhodopsin receptor 10) result in constitutive activation of second messenger production and are thought to play a role in disease pathophysiology. Constitutively active mutant receptors have been a valuable tool to demonstrate that certain ligands stabilize inactive conformations. Those ligands are known as inverse agonist, given that they have the opposite effect of agonists. Therefore, b-antagonists are used clinically to reduce heart rate and force of contraction in hypertension, angina and acute myocardial infarction by direct blocking endogenous catecholamine activity, [11][12][13] implying that inverse agonists may have preferred therapeutic applications in the pathophysiology of several cardiovascular diseases.In all seven transmembrane helix (TMH) of GPCRs it appears that the general mechanism of activation involves disruption of intramolecular constraints, leading to TMH movement and formation of new interactions, which stabilize the active state of the receptor. [14][15][16][17][18][19][20][21][22][23][24][25][26][27] The aspartic acid at position 104 in TMH II of the human b 1 -AR is conserved in all b-adrenergic 28-31) , a-adrenergic receptor 32) and also muscarinic cholinergic receptors, [33][34][35] which may take part in an ionic interaction with amino group containing catecholamines, whose disruption of interaction makes the receptor active conformation state. It was reported by Chung et al. 36) that aspartic acid residue at position 79 in putative TMH II of b 2 -AR was involved in agonist binding and receptor activation. Substitution of aspartic acid to alanine and asparagine at position 79 did not affect the antagonist binding but significantly decreased the binding affinity of agonists.
37)Moreover, this mutant receptor also affected the functional activity compared to wild type receptor by uncoupling with GPCRs.With the help of molecular modeling, we previously identified the important binding sites of b 1 -AR. We showed that Asp104 in TMH II of b 1 -AR makes strong electrostatic interaction with functional groups of SWR-0342SA.38) Through mutagenesis studies, we suggested that Asp104 is very important site for the ligand binding and functional...